Table 2.

Time to deterioration of functional status in FACT-P total scale and subscales

	25th percentile (95% CI)a, months		HR (95% CI)	P value
	Rezvilutamide plus ADT (n = 326)	Bicalutamide plus ADT (n = 328)
FACT-P total scale	12.8 (7.4–20.3)	6.0 (4.6–9.2)	0.66 (0.50–0.86)	0.002
Physical well-being	18.4 (8.3–36.8)	7.4 (5.6–11.1)	0.65 (0.49–0.86)	0.003
Social/family well-being	4.6 (3.6–6.5)	4.6 (3.7–5.6)	0.89 (0.70–1.13)	0.332
Emotional well-being	29.0 (14.9–NR)	12.4 (8.3–18.4)	0.68 (0.50–0.92)	0.013
Functional well-being	4.7 (3.7–6.5)	4.2 (2.8–5.5)	0.75 (0.59–0.95)	0.015
FACT-G general scale	12.8 (7.4–23.9)	8.4 (5.6–12.6)	0.69 (0.52–0.91)	0.008
Prostate cancer subscale	9.2 (6.5–13.8)	5.5 (3.8–7.3)	0.74 (0.57–0.96)	0.022
Trial outcome index	14.8 (7.4–27.6)	8.2 (5.7–11.1)	0.65 (0.49–0.86)	0.002
FACT-P pain scale	5.6 (3.7–7.4)	4.6 (3.7–6.2)	0.85 (0.67–1.08)	0.184

^aThe 25th percentiles were reported here because the majority of the median values had not been reached